FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase
- 18 April 2005
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 233 (1) , 36-47
- https://doi.org/10.1016/j.canlet.2005.02.039
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Expression of seven main Rho family members in gastric carcinomaBiochemical and Biophysical Research Communications, 2004
- Development of prostate cancer treatment: The good newsThe Prostate, 2004
- Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I studyTransplantation, 2003
- Induction of Apoptosis in Human Bladder Cancer Cells In Vitro and In Vivo Caused by FTY720 TreatmentJournal of Urology, 2003
- T cell selective apoptosis by a novel immunosuppressant, FTY720, is closely regulated with Bcl‐2British Journal of Pharmacology, 2002
- RHO–GTPases and cancerNature Reviews Cancer, 2002
- FTY720, a Novel Immunosuppressive Agent, Induces Apoptosis in Human Glioma CellsBiochemical and Biophysical Research Communications, 2001
- Rho-Kinase Inhibitor Retards Migration and in Vivo Dissemination of Human Prostate Cancer CellsBiochemical and Biophysical Research Communications, 2000
- Rho Family Proteins Modulate Rapid Apoptosis Induced by Cytotoxic T Lymphocytes and FasJournal of Biological Chemistry, 2000
- The Hallmarks of CancerCell, 2000